Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-561-0 | CAS number: 9046-10-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- no data
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Remarks:
- Limited information on study designs and methodology. Deviations from OECD Guideline 407: no data regarding observation period, test substance or animal husbandry; only 2 test groups were dosed compared to 3 test groups as recommended in the guideline; hematology, clinical biochemistry were not performed; no detailed data provided on gross autopsy results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 968
- Report date:
- 1968
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- Deviations:
- yes
- Remarks:
- No data provided regarding observation period, test substance or animal husbandry, only 2 test groups were dosed compared to 3 test groups as recommended in the guideline, hematology, clinical biochemistry were not performed.
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Test material form:
- liquid
- Details on test material:
- - Physical state: liquid
- Storage condition of test material: Room temperature
Constituent 1
- Specific details on test material used for the study:
- No test item information
Test animals
- Species:
- rat
- Strain:
- other: Albino (MR Wistar)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Mean weight at study initiation:
0% concentration in diet
113.3 g
0.083% concentration in diet
113.3 g
0.208% concentration in diet
113.4 g
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- not specified
- Details on oral exposure:
- No data on feeding conditions.
- Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- No data
- Duration of treatment / exposure:
- 31 days
- Frequency of treatment:
- daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 other: % nominal in diet
- Dose / conc.:
- 0.083 other: % nominal in diet
- Dose / conc.:
- 0.208 other: % nominal in diet
- No. of animals per sex per dose:
- 5 animals/sex/dose
- Control animals:
- yes
- Details on study design:
- No data
- Positive control:
- No data
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: No data
DETAILED CLINICAL OBSERVATIONS: No data
BODY WEIGHT: Yes
- Time schedule for examinations: No data
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No data
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No data
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No data
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data
OPHTHALMOSCOPIC EXAMINATION: No data
HAEMATOLOGY: No data
CLINICAL CHEMISTRY: No data
URINALYSIS: No data
NEUROBEHAVIOURAL EXAMINATION: No data - Sacrifice and pathology:
- GROSS PATHOLOGY: The animals were sacrificed at the end of the feeding period and were subjected to a thorough gross autopsy. Autopsy results were not provided.
HISTOPATHOLOGY: No data - Other examinations:
- Food intake; weight gain measured.
- Statistics:
- No data
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- The overall appearance of the treated and control animals was good.
- Mortality:
- no mortality observed
- Description (incidence):
- The overall appearance of the treated and control animals was good.
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- Since weight gain depends, in part, upon the amount of food consumed, the variances and covariance of body weight and food intake were analyzed. Male ate and gained significantly more than the females. There were no significant interactions between sex and treatment, indicating that the responses of males and females to the treatments were similar. Therefore, observations on males and females were combined for comparison of the treatment groups with the control group. There were no significant differences between the 0.208% group or the 0.083% group and the control group in mean food intake or mean weight gain, even after allowances were made for variations in food consumption.
- Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- Since weight gain depends, in part, upon the amount of food consumed, the variances and covariance of body weight and food intake were analyzed. Male ate and gained significantly more than the females. There were no significant interactions between sex and treatment, indicating that the responses of males and females to the treatments were similar. Therefore, observations on males and females were combined for comparison of the treatment groups with the control group. There were no significant differences between the 0.208% group or the 0.083% group and the control group in mean food intake or mean weight gain, even after allowances were made for variations in food consumption.
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- No relevant gross pathology was noted at autopsy in animals of either sex.
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- not specified
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
Effect levels
- Dose descriptor:
- NOEL
- Effect level:
- >= 0.208 other: %
- Based on:
- other: dietary concentrations
- Sex:
- male/female
- Basis for effect level:
- other: overall effects mortality; body weight; food consumption; gross pathology
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Summary of results of thirty-one daily doses in the diets of male and female albino rats |
|||
Concentration in diet (%) |
0 |
0.083 |
0.208 |
Number of rats (M +F) |
5+5 |
5+5 |
5+5 |
Mean dosage (g/kg/day) |
- |
0.093 |
0.239 |
Mean initial weight (g) |
113.3 |
113.3 |
113.4 |
Mean food intake (g) |
618.4 |
606.9 |
615.1 |
Mean weight gain (g) |
119.9 |
124.6 |
118.0 |
Mean weight gain, adjusted for food intake (g) |
119.0 |
124.2 |
118.7 |
Applicant's summary and conclusion
- Conclusions:
- Male and remale rats were exposed to 0.083 and 0.208% of the test substance incorporated into the diet in a 30 day repeated dose study. This 30 day exposure did not produce any mortality or evidence of systemic toxicity. No changes were observed for food intake, or body weight gain for the study animals. There were no histopathological findings noted on any of the study animals at necropsy. The no observable effect level (NOEL) for systemic toxicity was the highest dose level tested, 0.208%.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.